(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 5. Differential effect of TCE mutations on translational repression during
oogenesis and embryogenesis. (A) Northern analysis of total RNA from
nos-tub3'UTR (tub), nos-tub:TCE
(TCE) or nos-tub:TCE mutant (TCEIIA, TCE[SRE],
TCEIIIA) ovaries. Transgene RNAs, detected with a nos probe, were
normalized to the rp49 control to determine their relative abundance,
indicated below. (B) Immunoblot analysis of HA-Nos protein in extracts of
stage 14 egg chambers from wild-type (WT),
nos-tub3'UTR (tub), nos-tub:TCE
(TCE) or nos-tub:TCE mutant derivatives (TCEIIA,
TCE[SRE], TCEIIIA) using an anti-HA antibody. The antibody
crossreacts with a protein that co-migrates with HA-Nos, as well as a more
rapidly migrating protein in all samples. Snf protein was monitored as a
loading control. In stage 14 oocytes, the wild-type TCE and stem-loop II
mutants (TCEIIA, TCE[SRE]) prevent accumulation of HA-Nos,
whereas stem-loop III mutants (TCEIIIA and others shown in Fig. S2) do not.
Analysis of total ovarian extract [TCE(total)] confirms that
nos-tub:TCE RNA is expressed and translated at earlier stages of
oogenesis. (C) Immunoblot analysis of HA-Nos protein in extracts of stage 10
(st10) egg chambers and stage 14 (st14) oocytes dissected from
nos-tub:TCE (TCE) or wild-type ovaries. (D) Immunoblot analysis of
HA-Nos protein in extracts of total ovary or stage 14 (st14) oocytes from
nos-tub:TCE females mutant for smg
[smg1/Df(ScfR6)]. (E) Immunoblot
analysis of HA-Nos protein in extracts of embryos from the same transgenic and
wild-type lines shown in B. HA-Nos protein is detected in early embryos for
all of the TCE mutants.